Back

Medtronic CoreValve vs Edwards Sapien: a comparative analysis of efficacy, safety and mortality from an eight year nationwide registry

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Current data on TAVI outcomes Aortic Disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Pedro Canas da Silva

Santa Maria Hospital - CHULN, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Transcatheter aortic valve implantation: efficacy, safety and mortality at 30-days to 1-year from a nationwide eight year registry
Doctor P. Canas da Silva (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Impact of residual coronary artery disease on patients undergoing TAVI: a multicenter study
Doctor S. Taha (Assiut, EG)
Abstract Slides
Presentation thumbnail
Role of clopidogrel loading dose in patients undergoing transcatheter aortic valve implantation: results from the BRAVO-3 randomized trial
Mr V. Nijenhuis (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Effect of body mass index on mortality after transcatheter aortic valve implantation: J-shaped curve.
Ms R. GONZALEZ FERREIRO (Vigo, ES)
Abstract
Presentation thumbnail
Acute kidney injury following transcatheter aortic valve implantation: does it affect long-term outcomes?
Doctor A. Bacelar (Sao Paulo, BR)
Abstract Slides

Access the full session

Session thumbnail
Current data on TAVI outcomes

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources